Cell and gene therapy pricing is driven by market forces, explained David Rind, MD, MSc, and other experts.

Honorees Fernando Duarte, PhD, Sergio Giralt, MD, Joseph H. Antin, MD, and Robert Zeiser, MD, share some of the ideas that helped propel their careers.

This session on the manipulation of T-cell signaling includes fundamental discoveries and cutting-edge clinical advances, says Caitlin Zebley, MD, PhD.

Causal inference techniques are becoming increasingly important as researchers make use of large registry databases, explains Kwang Woo Ahn, PhD.

Experts outline the nuanced dynamics of international research, including the role of health technology assessment and real-world evidence in decision-making, in an opening-day plenary.

Experts including Jill Hollenbach, PhD, MPH, detailed new developments in clinically impactful translational research.

Warren Fingrut, MD, outlined a project to evaluate proactive financial navigation for patients with aplastic anemia.

Stephen Spellman, MBS, previews this session on recent age-focused research that has the potential to guide future studies and decisions in characterizing the optimal suitability of donors.